Arab participation in global genomic study could lead to new therapies for COVID patients
(Qatar Foundation) Researchers from Qatar, alongside researchers from 24 other countries, contributed to the COVID-19 Host Genetics Initiative large analysis identifying genetic markers for COVID risks, published today in Nature. The results of the analysis will enable genetic tests to predict the course of the disease, potential targeted therapies and drug repurposing to treat new infections and " long COVID " . It is the latest milestone establishing Qatar as a leading regional center for genomics research and precision medicine.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: COVID-19 | Genetics | Infectious Diseases | Middle East Health | Qatar Health | Study